Pressured by regulators, the German pharmaceutical giant Bayer AG announced Monday that it had agreed to withdraw the controversial heart surgery drug Trasylol after a Canadian study suggested that it increased death rates.Click here to access the article.
Tuesday, November 06, 2007
Heart drug withdrawn from market
From the New York Times article:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment